CHEK1 and Miyoshi myopathy: Samples from multiple myeloma (MM) patients exhibited significantly higher levels of Checkpoint Kinase 1 (CHEK1) expression than normal plasma cells, and elevated CHEK1 expression were linked to worse outcomes in MM patients.